1. Home
  2. IOVA vs TIPT Comparison

IOVA vs TIPT Comparison

Compare IOVA & TIPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOVA
  • TIPT
  • Stock Information
  • Founded
  • IOVA 2007
  • TIPT 2007
  • Country
  • IOVA United States
  • TIPT United States
  • Employees
  • IOVA N/A
  • TIPT N/A
  • Industry
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • TIPT Property-Casualty Insurers
  • Sector
  • IOVA Health Care
  • TIPT Finance
  • Exchange
  • IOVA Nasdaq
  • TIPT Nasdaq
  • Market Cap
  • IOVA 771.4M
  • TIPT 856.4M
  • IPO Year
  • IOVA N/A
  • TIPT 2007
  • Fundamental
  • Price
  • IOVA $1.88
  • TIPT $20.96
  • Analyst Decision
  • IOVA Buy
  • TIPT
  • Analyst Count
  • IOVA 10
  • TIPT 0
  • Target Price
  • IOVA $12.22
  • TIPT N/A
  • AVG Volume (30 Days)
  • IOVA 10.5M
  • TIPT 229.9K
  • Earning Date
  • IOVA 08-07-2025
  • TIPT 07-30-2025
  • Dividend Yield
  • IOVA N/A
  • TIPT 1.12%
  • EPS Growth
  • IOVA N/A
  • TIPT 107.58
  • EPS
  • IOVA N/A
  • TIPT 1.20
  • Revenue
  • IOVA $212,679,000.00
  • TIPT $2,042,059,000.00
  • Revenue This Year
  • IOVA $86.62
  • TIPT N/A
  • Revenue Next Year
  • IOVA $69.95
  • TIPT N/A
  • P/E Ratio
  • IOVA N/A
  • TIPT $17.40
  • Revenue Growth
  • IOVA 11070.12
  • TIPT 15.66
  • 52 Week Low
  • IOVA $1.64
  • TIPT $16.74
  • 52 Week High
  • IOVA $12.51
  • TIPT $26.90
  • Technical
  • Relative Strength Index (RSI)
  • IOVA 47.47
  • TIPT 38.94
  • Support Level
  • IOVA $1.68
  • TIPT $20.56
  • Resistance Level
  • IOVA $2.02
  • TIPT $24.30
  • Average True Range (ATR)
  • IOVA 0.11
  • TIPT 1.07
  • MACD
  • IOVA 0.03
  • TIPT -0.32
  • Stochastic Oscillator
  • IOVA 61.42
  • TIPT 9.52

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

About TIPT Tiptree Inc.

Tiptree Inc is a United States-based company that provides specialty insurance products and related services. It has two reportable segments: Insurance and Mortgage. The company generates the majority of its revenue from the Insurance Segment, which is engaged in designing, marketing, and underwriting specialty property and casualty insurance products incorporating value-added coverages and services for select target markets or niches. The Mortgage segment originates loans for sale to institutional investors, including GSEs and FHA/VA, and services loans on behalf of Fannie Mae, Freddie Mac, and Ginnie Mae.

Share on Social Networks: